Dear Members in Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases.

I am glad to inform all of you the newest journal status that according to the 2021 Journal Citation Reports, the 2020 Impact Factor for Journal of Infection and Chemotherapy (JIC) has increased to 2.211．
I would like to express my sincere gratitude to all the contributors who have submitted papers and provided reviews for JIC despite your busy schedules during the COVID-19 pandemic.
The journal's website and ScienceDirect have published a digital collection of published articles relating to COVID-19: Novel insight of SARS-CoV-2 and COVID-19 from the Journal of Infection and Chemotherapy.

We look forward to your continued submission of high-quality papers to support the ongoing growth and development of the journal.

8.17.2021

Editor-in-Chief, Journal of Infection and Chemotherapy

Satoshi Takahashi